Results 1 to 10 of about 32,962 (164)

Efficacy and safety of acupuncture for chemotherapy-induced nausea and vomiting: a systematic review and meta-analysis of randomized controlled trial [PDF]

Frontiers in Neurology
ObjectiveChemotherapy-induced nausea and vomiting (CINV) represents a common and debilitating side effects in cancer patients, often compromising treatment adherence and quality of life.
Jiongli Chen, Fangyue Xu, Lingyu Zhang, Shengyang Hu, Yaxuan Xu, Qiongbo Hua, Haitao Chen, Haitao Chen, Rongrong Li, Rongrong Li   +9 more
doaj   +2 more sources

Incidence and Risk Factors of Chemotherapy-Induced Nausea and Vomiting Among Adult Cancer Patients at Mbarara Regional Referral Hospital: A Prospective Study [PDF]

Clinical Pharmacology: Advances and Applications
Patrick Kitheka Muasya,1,2 Tadele Mekuriya Yadesa,1,3 John Isiiko,1,4 Julius Kyomya,1 Joel Oenga,1,2 Abubakar Amina,1,2 Godwin Nimusiima,1 Sebisaalu Joel,1 John Martin Tumwebaza,1,5 Kabera Radiana Makuza1 1Department of Pharmacy, Faculty of Medicine ...
Muasya PK, Yadesa TM, Isiiko J, Kyomya J, Oenga J, Amina A, Nimusiima G, Joel S, Tumwebaza JM, Makuza KR   +9 more
doaj   +2 more sources

Chemotherapy-Induced Nausea and Vomiting in Early Breast Cancer Patients Receiving Adjuvant Chemotherapy With Fluorouracil, Epirubicin, Cyclophosphamide Followed by Docetaxel Versus an Anthracycline-Free Regimen With Docetaxel, Cyclophosphamide-Results From a Randomized Clinical Trial. [PDF]

Int J Cancer
Chemotherapy‐induced nausea and vomiting (CINV) remains a significant clinical problem despite modern antiemetics. In particular, antiemetic strategies for emerging cancer therapies lack detailed evaluation. This randomized trial analyzed hourly CINV data for patients with early breast cancer who received either docetaxel plus cyclophosphamide (TC) or ...
Hörner M, Schäffler H, Häberle L, Goossens C, Pfister K, Leinert E, Veselinovic K, Brucker SY, Köhler U, Heinrich G, Schneeweiss A, Beckmann MW, Fasching PA, Janni W, Rack B, Heublein S, Ziegler P.   +16 more
europepmc   +2 more sources

Psychological Interventions in Chemotherapy-Induced Nausea and Vomiting in Women with Breast Cancer: A Systematic Review [PDF]

Iranian Journal of Medical Sciences, 2022
Background: Nausea and vomiting are considered the most common side effects of chemotherapy, and they can affect different dimensions of the lives of women with breast cancer. Thus, the management of these complications is of great significance.
Elahe Samami, Zohreh Shahhosseini, Zeinab Hamzehgardeshi, Forouzan Elyasi   +3 more
doaj   +1 more source

Nurses’ Performance Regarding Application of Acupressure Technique for Children undergoing Chemotherapy: An Assessment Study [PDF]

Egyptian Journal of Health Care, 2023
 Background: Chemotherapy-Induced Nausea and Vomiting is one of the most common side effects in pediatric patients undergoing chemotherapy despite the development of antiemetics, so assessing nurses for knowledge and skills about chemotherapy-induced ...
Randa Mohammed Adly, Hanaa Gaber Mohammed, Sabah Saad AL-Sharkawi   +2 more
doaj   +1 more source

Effect of Foot Massage on Patients with Chemotherapy Induced Nausea and Vomiting: A Randomized Clinical Trial [PDF]

Journal of Caring Sciences, 2020
Introduction: Cancer is a global problem and it is a leading cause of death worldwide. Nausea, vomiting and retching are one of the common side effects that are seen among the majority of the patients undergoing chemotherapy.
Cluny Asha, Kumari Jayaram Manjini, Biswajit Dubashi   +2 more
doaj   +1 more source

Effect of Inhaled Peppermint Aromatherapy on Chemotherapy-Induced Acute Nausea and Vomiting among Women with Breast Cancer in Gresik Regency

Indonesian Journal of Cancer, 2023
Background: Chemotherapy-induced acute nausea and vomiting are commonly experienced by breast cancer patients. Therefore, this study aimed to determine the effect of inhaled peppermint aromatherapy on chemotherapy-induced acute nausea and vomiting among ...
Istiroha Istiroha, Roihatul Zahroh, Qonitatin Wafiyah, Yuanita Syaiful   +3 more
doaj   +1 more source

Comparative Study of an Ondansetron and a Ramosetron an Aprepitant in the Control of Nausea and Vomiting in Gynecologinc Cancer Patient with Chemotherapy [PDF]

Kosin Medical Journal, 2013
ResultsThe efficacy of controlling nausea with an ondansetron regimen and a ramosetron regimen and an aprepitant regimen was 85.29%, 78.26%, 80% in acute periods (P-value = 0.037) and 88.23%, 98.26%, 87.5% in delayed periods (P-value = 0.000 ...
HANGGOO Yun, Heung Yeol Kim, Eun ae Jeh
doaj   +1 more source

Shanghai expert consensus on whole-process management of antineoplastic-induced nausea and vomiting (2024 edition) [PDF]

Zhongguo aizheng zazhi
Nausea and vomiting are common adverse reactions in tumor patients during anti-tumor therapy such as chemotherapy, radiotherapy, targeted therapy and immunotherapy.
Cancer Rehabilitation and Palliative Professional Committee of Shanghai Anti-Cancer Association, Cancer Drug Clinical Research Committee of Shanghai Anti-Cancer Association, Cancer Prevention and Clinical Research Committee of Chinese Aging Well Association   +2 more
doaj   +2 more sources

Patient‐Reported Outcomes with Selpercatinib Treatment Among Patients with RET‐Mutant Medullary Thyroid Cancer in the Phase I/II LIBRETTO‐001 Trial

The Oncologist, EarlyView., 2021
Abstract Background Medullary thyroid cancer (MTC) standard of care includes multikinase inhibitors (MKIs), which can exacerbate disease‐related diarrhea, primarily because of non‐RET kinase inhibition. We report diarrhea and other patient‐reported outcomes (PROs) with selpercatinib, a highly selective RET inhibitor, among patients with RET‐mutant MTC ...
Lori J. Wirth, Bruce Robinson, Valentina Boni, Daniel S.W. Tan, Caroline McCoach, Erminia Massarelli, Lisa M. Hess, Min‐Hua Jen, Jennifer Kherani, Elizabeth Olek, Vivek Subbiah   +10 more
wiley   +1 more source